Team

4baseCare’s interdisciplinary team of experts join hands and consistently works towards a common vision and belief – Together, We Beat Cancer.

Our Leadership Team

Hitesh Goswami

Co-Founder & CEO

Kshitij Rishi

Co-Founder & COO

Dr. Giridharan Periyasamy

Chief Scientific Officer

Puneet Pantane

Chief Digital Officer

Praveen Jha

Vice President - Commercial Operations

Dr. Sudharshan Elangovan

Vice President-Global Operations & Regulations
Dr.Anjali Kulkarni

Dr. Anjali Kulkarni

Vice President - RWE Strategy and Analytics

Sreekanth Tangirala

Head of Engineering

Dr. Vidya H Veldore

Vice President-Clinical Operations

Prof. George Church

Professor @ Harvard & MIT, USA

Dr. Amit Dutt

Cancer Researcher at Tata Memorial
(ACTREC), India

Dr.Sandeep Nayak

Director
Department of Surgical Oncology, Fortis Hospital

Dr. Kumar Prabhash

Professor
medical oncologist Tata Memorial Hospital

Francis deSouza

CEO & Co Founder
SynthLabs

Lip-Bu Tan

Chairman of Walden International and Founding Managing Partner
at Walden Catalyst Ventures

Advisors

Science/ Genomics/ Research

Hitesh Goswami

Co-Founder & CEO

Kshitij Rishi

Co-Founder & COO

Dr. Giridharan Periyasamy

Chief Scientific Officer

Puneet Pantane

Chief Digital Officer

Praveen Jha

Vice President - Commercial Operations

Dr. Sudharshan Elangovan

Vice President-Global Operations & Regulations
Dr.Anjali Kulkarni

Dr. Anjali Kulkarni

Vice President - RWE Strategy and Analytics

Sreekanth Tangirala

Head of Engineering

Dr. Vidya H Veldore

Vice President-Clinical Operations

Prof. George Church

Professor @ Harvard & MIT, USA

Dr. Amit Dutt

Cancer Researcher at Tata Memorial
(ACTREC), India

Dr.Sandeep Nayak

Director
Department of Surgical Oncology, Fortis Hospital

Dr. Kumar Prabhash

Professor
medical oncologist Tata Memorial Hospital

Francis deSouza

CEO & Co Founder
SynthLabs

Lip-Bu Tan

Chairman of Walden International and Founding Managing Partner
at Walden Catalyst Ventures

Dr. Vidya H Veldore

Vice President-Clinical Operations
ln

Dr. Vidya H Veldore is a seasoned leader with over 19 years of experience in clinical operations, cancer genomics, and life sciences. She holds a strong academic foundation from the prestigious Indian Institute of Science (IISc) and has held critical roles in leading organizations like MedGenome and HCG (HealthCare Global). In her role as Vice President of Clinical Operations at 4baseCare, Vidya spearheads initiatives that bridge advanced clinical strategies with precision oncology, driving operational excellence and enhancing patient outcomes. Her expertise lies in molecular biology, clinical research, and the development of transformative solutions in genomics to advance cancer care.

Dr Vidya had been instrumental in bringing cost effective solutions from bedside-to-bench-to-bedside, through translational research studies, ensuring impactful clinical applications in cancer care. She had played a pioneering role in the design, development, and clinical validation of Liquid Biopsy NGS testing for cancer patients, making it the first of its kind to be launched in India. She also contributed significantly by co-mentoring DNB Postgraduate Students specializing in oncology domains such as medical, surgical, radiation oncology, and molecular pathology

Sreekanth Tangirala

Head of Engineering
ln

Sreekanth Tangirala is a results-driven technology leader with over 15 years of experience spanning solution architecture, product development, and engineering leadership. As the Head of Engineering at 4baseCare, he oversees the strategic management of people, products, and processes while driving innovation in both internal and client-facing applications. Sreekanth specializes in designing and delivering scalable solutions using microservices architecture, AWS cloud infrastructure, and cutting-edge web and mobile technologies.

With a proven track record in team leadership, UX/UI design, and AI/ML integration, Sreekanth has successfully transformed traditional processes into efficient digital solutions. His expertise in multiple development tools, technologies, programming languages along with cloud providers enables him to deliver high-quality, impactful products across healthcare, logistics, and finance domains.

Dr.Anjali Kulkarni

Dr. Anjali Kulkarni

Vice President - RWE Strategy and Analytics
ln

Dr. Anjali Kulkarni, V.P. of RWE Strategy and Analytics at 4baseCare, is a distinguished leader in Clinical Oncology and Healthcare technologies. With a profound expertise in AI-driven cancer treatment systems and real-world evidence clinical data, she has a proven track record of creating patient-centric solutions and driving technology adoption among clinicians. Dr. Kulkarni’s strategic vision and leadership in leveraging data for precision medicine are pivotal in advancing diagnostic data and treatment patterns, making her an indispensable asset to 4baseCare’s mission of transforming healthcare.

Dr. Sudharshan Elangovan

Vice President-Global Operations & Regulations
ln

Dr. Sudharshan Elangovan is a transformational leader with over 15 years of experience in genomics, oncology, and precision medicine. He holds a Ph.D. in Translational & Molecular Medicine from Università degli Studi di Milano-Bicocca and has held key roles at organizations like Wipro Life Sciences and Humanitas University. Specializing in regulatory compliance, NGS testing, and laboratory operations, Dr. Elangovan drives impactful initiatives that bridge genomic innovations with clinical applications. His expertise in operational excellence and multidisciplinary collaboration has been instrumental in enhancing patient outcomes and advancing precision medicine.

Praveen Jha

Vice President - Commercial Operations
ln

Praveen Jha is a seasoned life sciences healthcare professional with over 20 years of experience across diverse sectors, including Genomics, Diagnostics, Pharmaceuticals, Medical Devices, Health Nutrition, and Insurance. He has demonstrated several instances of organic growth across companies, leading to roles of increasing complexity and responsibility. With extensive experience working across India, Praveen brings a deep understanding of the commercial landscape and a proven track record of driving growth and innovation.

Puneet Pantane

Chief Digital Officer
ln

Puneet Pantane is a global leader in digital healthcare transformation, with over 20 years of experience driving innovation through technology. His expertise spans radiology, pathology, cardiology, critical care, and advanced technologies like AI, ML, and NLP. During his 18 years at GE HealthCare, Puneet spearheaded the development of digital healthcare solutions now implemented in over 60 countries. As the co-founder of Crosscope, he built AI-powered algorithms for cancer detection, demonstrating his ability to turn cutting-edge technology into impactful solutions. Crosscope’s successful acquisition by a U.S.-based healthcare company further highlights his entrepreneurial and strategic vision.

With extensive experience across the U.S., Europe, and Asia, Puneet combines deep clinical workflow knowledge with advanced technological insights. His passion for patient-centric care aligns with his vision of transforming healthcare to positively impact “1 billion lives.” As Chief Digital Officer, Puneet leads 4baseCare’s digital transformation strategy, harnessing innovation and domain expertise to redefine healthcare delivery and improve outcomes globally.

Lip-Bu Tan

Chairman of Walden International and Founding Managing Partner
at Walden Catalyst Ventures
ln

Lip-Bu Tan is a Deep Tech Visionary and renowned venture capitalist with over 30 years of experience in driving innovation across technology, big data, and precision healthcare. He is the Founder & Chairman of Walden International and Founding Managing Partner at Walden Catalyst Ventures, where he has played a pivotal role in advancing cutting-edge technologies and startups globally.

Lip-Bu also serves as the Chairman of Greenstone Biosciences, a board member and investor at Artera.ai, and an anchor investor and advisor at Yali Capital, which led 4baseCare’s $6 Million Series A funding. With a strong foundation as a nuclear engineer from MIT and decades of leadership experience, he brings unparalleled expertise in deep tech and venture capital.

His strategic insights and extensive network are invaluable as 4baseCare accelerates its mission to revolutionize precision oncology and impact the lives of millions of cancer patients worldwide.

Francis deSouza

CEO & Co Founder
SynthLabs
ln

Francis deSouza is a visionary leader, entrepreneur, and technology expert with over 30 years of experience driving innovation in genomics, technology, and healthcare. As the former CEO of Illumina, he led groundbreaking initiatives that advanced precision medicine and expanded access to genomics globally.

Francis has an exceptional track record of building and scaling technology-driven companies, having co-founded ventures like SynthLabs (focused on AI alignment) and IMlogic (acquired by Symantec). He has also held leadership positions at Microsoft and Symantec, where he contributed to advancements in enterprise security, product innovation, and digital transformation.

As an advisor to 4baseCare, Francis brings deep expertise in genomics, strategic leadership, and global expansion. His passion for making genomics accessible and impactful aligns perfectly with 4baseCare’s mission to revolutionize cancer care through precision oncology and digital health technologies.

Dr. Kumar Prabhash

Professor
medical oncologist Tata Memorial Hospital
ln

Dr.Kumar is a professor and medical oncologist at Tata Memorial Hospital with an experience of two decades in Oncology. Being the President and Convener of the Indian Cooperative Oncology Network (ICON), he has dedicated his life to creating awareness about lung cancer with utmost importance to patient care and to strengthening future research.

Dr.Sandeep Nayak

Director
Department of Surgical Oncology, Fortis Hospital
ln

Dr Nayak is the Director, Department of Surgical Oncology, Fortis Hospital, Bannerghatta Road. A pioneer in Laparoscopic Surgery for the treatment of Cancer, Dr. Sandeep Nayak is one of the most eminent experts in Surgical Oncology with extensive experience of 20 years in open Laparoscopic & Robotic Cancer Surgeries.

Dr. Giridharan Periyasamy

Chief Scientific Officer
ln

Dr. Giridharan Periyasamy holds a Ph.D. in Cancer Biology and Drug Discovery and brings over 22 years of rich experience from academia and industry. He has held pivotal roles at esteemed institutions such as Piramal Life Sciences, Mumbai, CCAMP-NCBS, Bangalore, and A*STAR-Singapore’s Genome Institute and Experimental Drug Discovery Centre. Dr. Periyasamy is an authority in disease biology, discovery genomics, and therapeutic innovation, proficient in setting up advanced in vitro tool-box development and leveraging patient-centric translational platforms for biomarker development and precision health.

Dr. Amit Dutt

Cancer Researcher at Tata Memorial
(ACTREC), India
ln

Dr. Dutt is a Principal Investigator at ACTREC, Tata Memorial Centre, Mumbai. His laboratory focuses on understanding the somatic changes that occur in human cancer cells and how these changes can help develop the next generation of effective targeted therapies to improve the treatment of cancer patients. Dr. Dutt obtained his Ph.D from  the  University of Zurich, Switzerland and ICGEB/ JMI, New Delhi. He was a postdoctoral fellow at the Broad Institute of Harvard and MIT. Dr. Dutt serves on the Editorial Board of PLOS ONE; BMC Genomics; on the scientific advisory committee and screening/ selection committee of various government and private organizations; and, is a faculty member in Medical Genetics- F1000 Prime.

He is a recipient of the Swiss National Science Foundation fellowship award; the Julius Klaus Foundation award from the University of Zurich; the Ramalingaswami Fellowship Award from the Department of Biotechnology (DBT); the Wellcome Trust/ DBT India Alliance Intermediate Fellowship Award; YIM Boston Young Scientist Award; Outstanding Alumni award from JMI, and the Shanti Swarup Bhatnagar Award in the field of Medical Sciences 2017.

Prof. George Church

Professor @ Harvard & MIT, USA
ln

Maverick scientist, Prof Church is famously known as Father of synthetic biology” (Professor at Harvard Medical School and MIT). Having co-pioneered direct genome sequencing and initiated an ambitious Personal Genome Project (PGP), his most recent ambitious project includes an attempt at resurrecting long-extinct Wooly Mammoth. Prof Church has also Featured in Time’s 100 Most Influential People, National Geographic, and the Colbert Show.

Kshitij Rishi

Co-Founder & COO
ln

Kshitij is a co-founder and COO at 4baseCare. He oversees the end-to-end operations of the company including building the network and collaborations with hospitals/clinicians, patient enrolment, logistics, and building a functional and independent “CARE” team with Care managers, Care Companions, NGO’s, and counselors to provide Allied CARE and support to the patients.

Alumni of XLRI, Kshitij has had his share of earlier entrepreneurial experience before becoming part of larger organizations like Deloitte and GE where he has taken senior leadership roles in strategy consulting, operations, and marketing.

Hitesh Goswami

Co-Founder & CEO
ln

Hitesh is a co-founder and CEO of 4baseCare. He oversees operations across the complete business cycle – Clinical oncology, Research and Development, Collaborations, Genomics, Technology, Business Development, Sales Operations,  and other Corporate functions.

Hitesh is also co-founder of leading Genome “IT” company, Bionivid Technology (founded in 2011) which provides niche IT solutions to handle Genomics BIG DATA challenges which include analytics, data processing, storage, and training/education and awareness in the domain of Genomics and Genome Informatics.

He has 12+ years of experience in pharma drug discovery and Genomics. Prior to his entrepreneur journey, Hitesh was part of the High throughput screening and drug discovery team at Piramal Lifesciences (then called Nicholas Piramal Research Centre) working on identifying novel small molecules and formulations for their efficacy in therapeutic areas like Cancer, Inflammation, and Diabetes.

loader